PT-112-101 A Phase I, Open-Label, Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-122 Injection in Subjects with Advanced Solid Tumors
Primary Objective
This is a clinical trial of PT-112 that will be administered injection which is investigational.
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Scope
National
Locations
Outpatient CTRC
University of Colorado Hospital
Study ID
Protocol Number: 14-0151
More information available at ClinicalTrials.gov: NCT02266745
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers